FP04-MO-05 Neurological signs of Wilson' disease assessed by unified Wilson's disease rating scale (UWDRS)

2009 ◽  
Vol 285 ◽  
pp. S63
Author(s):  
A. Czlonkowska ◽  
C. Möller ◽  
G. Chabik ◽  
M. Lesniak ◽  
T. Litwin ◽  
...  
2007 ◽  
Vol 13 ◽  
pp. S80 ◽  
Author(s):  
A. Czlonkowska ◽  
B. Tarnacka ◽  
J. Carsten Möller ◽  
B. Leinweber ◽  
W.H. Oertel ◽  
...  

2008 ◽  
Vol 23 (1) ◽  
pp. 54-62 ◽  
Author(s):  
Barbara Leinweber ◽  
J. Carsten Möller ◽  
Andre Scherag ◽  
Ulrike Reuner ◽  
Peter Günther ◽  
...  

2016 ◽  
Vol 10 (4) ◽  
pp. 320-326 ◽  
Author(s):  
Norberto Anízio Ferreira Frota ◽  
Egberto Reis Barbosa ◽  
Claudia Sellitto Porto ◽  
Leandro Tavares Lucato ◽  
Carla Rachel Ono ◽  
...  

ABSTRACT Background: Patients with Wilson's disease (WD) present cognitive impairment, especially in executive functions. Which other factors might be associated with global cognitive decline in these patients remains unclear. Objective: To assess which factors are associated with worse performance on a global cognitive test in patients with WD. Methods: Twenty patients with WD underwent cognitive assessment with the following tests: the Mini-Mental State Examination (MMSE), Dementia Rating Scale (DRS), verbal fluency test, brief cognitive battery, clock drawing test, Frontal Assessment Battery, Stroop test, Wisconsin card sorting test, Hopper test, cubes (WAIS) and the Pfeffer questionnaire. MRI changes were quantified. Patients with poor performance on the DRS were compared to patients with normal performance. Results: Nine patients had a poor performance on the DRS. This group had lower educational level (9.11±3.58 × 12.82±3.06) and a greater number of changes on MRI (9.44±2.74 × 6.27±2.45). The presence of hyperintensity in the globus pallidus on MRI was more frequent in this group (66.6% vs 9.0%), with OR=5.38 (95% CI 0.85-33.86). Conclusion: Global cognitive impairment was prevalent in this sample of patients with WD and was associated with low educational level, number of changes on MRI and MRI hyperintensity in the globus pallidus.


Author(s):  
Harun Özmen ◽  
Bahar Aydınlı

Wilson's disease is an autosomal recessive inherited chronic disease that occurs as a result of the deposition of copper in organs and tissues with impaired biliary excretion. With this case report, we aimed to share our experience in cesarean anesthesia in a pregnant woman with Wilson disease who had irregular medical follow-up and underwent chelation therapy.


Author(s):  
Marcin Leśniak ◽  
Magdalena Roessler-Górecka ◽  
Anna Członkowska ◽  
Joanna Seniów

Abstract Background and aim Apathy is one of the neuropsychiatric symptoms of Wilson’s disease (WD) which typically affects the brain’s fronto-basal circuits. Lack of agreed diagnostic criteria and common use of self-description assessment tools lead to underestimation of this clinical phenomenon. The aim of this study was to investigate whether subjective and informant-based clinical features of apathy in patients with WD enable clinicians to make a valid diagnosis. Methods Multiple aspects of goal-oriented behavior were assessed in 30 patients with the neurological form of WD and 30 age-matched healthy participants using two questionnaires, the Lille Apathy Rating Scale (LARS) and the Dysexecutive Questionnaire (DEX). Both included a self-descriptive and a caregiver/proxy version. Cognitive functioning was estimated with the use of Addenbrooke’s Cognitive Examination-Revised. Results Patients obtained significantly worse scores on all clinical scales when more objective measures were considered. Features of apathy and executive dysfunction were revealed in patients’ caregiver versions of LARS and DEX, which may indicate poor self-awareness of patients with WD. Roughly 30% of participants were likely to present with clinically meaningful symptoms, independent of cognitive dysfunction. Conclusions Methods relying on self-description appear inferior to informant-based scales when diagnosing apathy. More objective criteria and measurement tools are needed to better understand this clinical syndrome.


2009 ◽  
Vol 3 (1) ◽  
pp. 16-21 ◽  
Author(s):  
Norberto Anizio Ferreira Frota ◽  
Paulo Caramelli ◽  
Egberto Reis Barbosa

Abstract Wilson's disease (WD) or hepatolenticular degeneration is a rare, genetic and systemic disease, caused by a deficit in the metabolism of copper, leading to its accumulation in different organs, mainly the liver, followed by the central nervous system, especially the basal ganglia. When symptoms begin between the second and third decades of life, approximately 50% of the patients show neurological symptoms. Although dystonia and dysarthria are the most common neurological signs, cognitive changes have been reported since the first cases were described in 1912. Memory change is one of the most common impairments, but other cognitive changes have been reported, including dementia in untreated cases. In this article we review the cognitive changes in WD patients and the occurrence of dementia.


2019 ◽  
Vol 9 (1) ◽  
pp. 5-6
Author(s):  
Ouidad Louachama ◽  
Aicha Bourrahouat ◽  
Ibtissam Khattou ◽  
Imane Ait Sab ◽  
Mohamed Sbihi

Wilson disease (WD) is a disorder of copper metabolism. Liver and brain disorders are the main presentations, hemolytic anemia in WD is a rare inaugural symptom. We report a case of a child who developed recurrent hemolytic anemia associated with liver failure in the second hemolysis episode as the first manifestation of WD. Wilson's disease is not exceptional in children with hemolytic anemia, but another differential diagnosis must be excluded.


Sign in / Sign up

Export Citation Format

Share Document